Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Current Oncology Reports
|
March 29, 2022
Anti-PD-1: When to Stop Treatment
Y Jansen, A A M van der Veldt, G Awada, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 15, 2007
[Adverse effects of the tyrosine-kinase inhibitor sunitinib, a new drug for the treatment of advanced renal-cell cancer]
A A M van der Veldt, A J M van den Eertwegh, E Boven
The Netherlands Journal of Medicine
|
October 24, 2007
Verapamil-induced erythermalgia
P W B Nanayakkara, A A M van der Veldt, S Simsek, et al.
Clinical Endocrinology
|
September 18, 2007
Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules
L Hooft, A A M van der Veldt, O S Hoekstra, et al.
British Journal of Cancer
|
February 11, 2010
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
A A M van der Veldt, M R Meijerink, A J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2025
4-year overall survival after the introduction of adjuvant therapy for patients with stage III melanoma: A population-based study
J C Janssen, A W Schurink, C Verhoef, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 29, 2004
[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor
L Hooft, A A M van der Veldt, P J van Diest, et al.
ESMO Open
|
November 15, 2021
Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation
E E A P Mulder, L Smit, D J Grünhagen, et al.
Frontiers in Immunology
|
February 22, 2021
Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition
K de Joode, A A M Oostvogels, C H GeurtsvanKessel, et al.
Cancer Treatment Reviews
|
November 1, 2024
Local administration of immunotherapy for patients with skin cancer: A systematic review
J C Janssen, B van Dijk, L L Hoeijmakers, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Current Oncology Reports
|
March 29, 2022
Anti-PD-1: When to Stop Treatment
Y Jansen, A A M van der Veldt, G Awada, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 15, 2007
[Adverse effects of the tyrosine-kinase inhibitor sunitinib, a new drug for the treatment of advanced renal-cell cancer]
A A M van der Veldt, A J M van den Eertwegh, E Boven
The Netherlands Journal of Medicine
|
October 24, 2007
Verapamil-induced erythermalgia
P W B Nanayakkara, A A M van der Veldt, S Simsek, et al.
Clinical Endocrinology
|
September 18, 2007
Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules
L Hooft, A A M van der Veldt, O S Hoekstra, et al.
British Journal of Cancer
|
February 11, 2010
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
A A M van der Veldt, M R Meijerink, A J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2025
4-year overall survival after the introduction of adjuvant therapy for patients with stage III melanoma: A population-based study
J C Janssen, A W Schurink, C Verhoef, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 29, 2004
[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor
L Hooft, A A M van der Veldt, P J van Diest, et al.
ESMO Open
|
November 15, 2021
Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation
E E A P Mulder, L Smit, D J Grünhagen, et al.
Frontiers in Immunology
|
February 22, 2021
Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition
K de Joode, A A M Oostvogels, C H GeurtsvanKessel, et al.
Cancer Treatment Reviews
|
November 1, 2024
Local administration of immunotherapy for patients with skin cancer: A systematic review
J C Janssen, B van Dijk, L L Hoeijmakers, et al.
Page
of 3